Low Dose Tamoxifen in Hodgkin Lymphoma Survivors for Bre

Project: Research project

Project Details

Description

Low Dose Tamoxifen in Hodgkin Lymphoma Survivors for Breast Cancer Risk
StatusFinished
Effective start/end date6/1/1312/31/14

Funding

  • BECKMAN RES. INST. OF THE CITY OF HOPE
  • NIH NATIONAL CANCER INSTITUTE (NCI)

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.